-
公开(公告)号：US20140248353A1
公开(公告)日：2014-09-04
申请号：US14280117
申请日：2014-05-16
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
IPC分类号： A61K9/70 , A61K31/4196 , A61K47/26 , A61K47/36 , A61K31/445 , A61K31/4439 , A61K31/495 , A61K31/422 , A61K31/4045 , A61K31/192 , A61K9/00 , A61K47/32
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
摘要翻译： 作为用于递送药物活性剂的可生物降解的水溶性薄膜，通过插入到患者口中的患者的口服剂型和通过插入到口中向患者施用药物活性剂以通过粘膜选择性吸收所述药物的方法，以及 从而避免胃肠道。
-
公开(公告)号：US20150320695A1
公开(公告)日：2015-11-12
申请号：US14803757
申请日：2015-07-20
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
摘要翻译： 作为用于递送药物活性剂的可生物降解的水溶性薄膜，通过插入到患者口中的患者的口服剂型和通过插入到口中向患者施用药物活性剂以通过粘膜选择性吸收所述药物的方法，以及 从而避免胃肠道。
-
公开(公告)号：US20150258036A1
公开(公告)日：2015-09-17
申请号：US14627899
申请日：2015-02-20
发明人： Hoo-Kyun CHOI
CPC分类号： A61M35/00 , A61K9/7053 , A61K9/7069 , A61K9/7076 , A61K31/445
摘要： Certain embodiments of the invention relates to a transdermal drug delivery system containing donepezil or a pharmaceutically acceptable salt thereof as an active ingredient, more specifically to a transdermal drug delivery system containing a drug-containing matrix layer comprising donepezil or its pharmaceutically acceptable salt, a styrene copolymer, a hydrogenated rosin glycerol ester, and optionally a hydrocarbon resin.
摘要翻译： 本发明的某些实施方案涉及含有多奈哌齐或其药学上可接受的盐作为活性成分的透皮药物递送系统，更具体地涉及包含含有多奈哌齐或其药学上可接受的盐的药物基质层的透皮药物递送系统，苯乙烯 共聚物，氢化松香甘油酯和任选的烃树脂。
-
公开(公告)号：US09114075B2
公开(公告)日：2015-08-25
申请号：US14309120
申请日：2014-06-19
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
IPC分类号： A61K31/00 , A61K9/00 , A61K31/4196 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K9/20 , A61K9/70 , A61K31/192 , A61K31/4045 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/495 , A61K31/55 , A61K38/05 , A61K31/465 , A61K31/78 , A61K31/196 , A61K31/421 , A61K31/4468
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
摘要翻译： 作为用于递送药物活性剂的可生物降解的水溶性薄膜，通过插入到患者口中的患者的口服剂型和通过插入到口中向患者施用药物活性剂以通过粘膜选择性吸收所述药物的方法，以及 从而避免胃肠道。
-
公开(公告)号：US20150352058A1
公开(公告)日：2015-12-10
申请号：US14825071
申请日：2015-08-12
发明人： Y. Joseph Mo
IPC分类号： A61K9/70 , A61K47/10 , A61K31/445
CPC分类号： A61K9/7046 , A61K9/7053 , A61K9/7061 , A61K31/445 , A61K47/10
摘要： The present invention provides a transdermal drug delivery system comprising a drug-containing matrix layer comprising: (a) donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; and (b) an acrylate-rubber hybrid as an adhesive.
摘要翻译： 本发明提供了包含含药基质层的透皮药物递送系统，其包含：（a）多奈哌齐或其药学上可接受的盐作为活性成分; 和（b）作为粘合剂的丙烯酸酯 - 橡胶混合物。
-
公开(公告)号：US09114073B2
公开(公告)日：2015-08-25
申请号：US14280033
申请日：2014-05-16
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
IPC分类号： A61K31/78 , A61K9/00 , A61K31/00 , A61K31/4196 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K9/20 , A61K9/70 , A61K31/192 , A61K31/4045 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/495 , A61K31/55 , A61K38/05 , A61K31/465 , A61K31/196 , A61K31/421 , A61K31/4468
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
-
公开(公告)号：US08900634B2
公开(公告)日：2014-12-02
申请号：US13040143
申请日：2011-03-03
申请人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang , Diana Shu-Lian Chow , Roland A. Ako
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang , Diana Shu-Lian Chow , Roland A. Ako
CPC分类号： A61K31/05 , A61K9/006 , A61K9/7007 , A61K31/56
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, particularly diethylstilbestrol and pharmaceutically acceptable salts thereof to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
摘要翻译： 作为可生物降解的水溶性膜的口服剂型，用于通过插入患者口中向患者输送药物活性剂，特别是己烯雌酚和其药学上可接受的盐，以及通过插入口中向患者施用药物活性剂以提供选择性摄取 的所述药物通过粘膜，从而避免胃肠道。
-
公开(公告)号：US09155711B2
公开(公告)日：2015-10-13
申请号：US13806565
申请日：2011-04-27
申请人： Hoo-Kyun Choi , Myung-Kwan Chun , Y. Joseph Mo
发明人： Hoo-Kyun Choi , Myung-Kwan Chun , Y. Joseph Mo
IPC分类号： A61K9/70 , A61K31/445
CPC分类号： A61K9/7046 , A61K9/7053 , A61K9/7061 , A61K31/445 , A61K47/10
摘要： The present invention provides a transdermal drug delivery system comprising a drug-containing matrix layer comprising: (a) donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; and (b) an acrylate-rubber hybrid as an adhesive.
摘要翻译： 本发明提供了包含含药基质层的透皮药物递送系统，其包含：（a）多奈哌齐或其药学上可接受的盐作为活性成分; 和（b）作为粘合剂的丙烯酸酯 - 橡胶混合物。
-
公开(公告)号：US09119776B2
公开(公告)日：2015-09-01
申请号：US14309179
申请日：2014-06-19
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
IPC分类号： A61K9/00 , A61K31/00 , A61K31/4196 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K9/20 , A61K9/70 , A61K31/192 , A61K31/4045 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/495 , A61K31/55 , A61K38/05 , A61K31/465 , A61K31/78 , A61K31/196 , A61K31/421 , A61K31/4468
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
-
公开(公告)号：US09114074B2
公开(公告)日：2015-08-25
申请号：US14280117
申请日：2014-05-16
发明人： Je Phil Ryoo , Chun Kwong Chu , Zheng Wang
IPC分类号： A61K31/00 , A61K9/00 , A61K31/4196 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K9/20 , A61K9/70 , A61K31/192 , A61K31/4045 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/495 , A61K31/55 , A61K38/05 , A61K31/465 , A61K31/78 , A61K31/196 , A61K31/421 , A61K31/4468
CPC分类号： A61K9/7015 , A61K9/0056 , A61K9/006 , A61K9/0095 , A61K9/2018 , A61K9/2027 , A61K9/7007 , A61K31/00 , A61K31/192 , A61K31/196 , A61K31/4045 , A61K31/4196 , A61K31/421 , A61K31/422 , A61K31/4439 , A61K31/445 , A61K31/4468 , A61K31/465 , A61K31/495 , A61K31/55 , A61K31/78 , A61K38/05 , A61K38/06 , A61K47/26 , A61K47/32 , A61K47/36 , A61K47/38 , A61K2300/00
摘要： Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract.
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.017 秒)
